Systemic complications of traumatic brain injury

Current Opinion in Anaesthesiology

Volumn 28, Issue 5, 2015, Pages 525-531

  Wijayatilakea, Dhuleep S ^a,b   Sherren, Peter B ^c   Jigajinni, Suyogi V ^d  

^a QUEEN S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d Queens Hospital   (United Kingdom)

Author keywords

Intracranial pressure; Neurocritical care; Systemic complications; Traumatic brain injury

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; ENDOCRINE DISEASE; ENDOCRINOLOGY; HEMATOLOGIC DISEASE; HEMATOLOGY; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASE; REVIEW; TRAUMATIC BRAIN INJURY; BRAIN INJURIES; COMPLICATION; INTENSIVE CARE; INTRACRANIAL PRESSURE; PATHOPHYSIOLOGY; PROCEDURES;

BRAIN INJURIES; CRITICAL CARE; HUMANS; INTRACRANIAL PRESSURE;

EID: 84973495075     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000236     Document Type: Review

References (49)

1. Zygun DA, Kortbeek JB, Fick GH, et al. Nonneurologic organ dysfunction in severe traumatic brain injury. Crit Care Med 2005; 33:654- 660.
2. Sedy J, Kunes J, Zicha J. Pathogenetic mechanisms of neurogenic pulmonary edema. J Neurotrauma 2015; 32:1135-1145.
3. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve -An integrative interface between two supersystems: The brain and the immune system. Pharmacol Rev 2000; 52:595-638.
4. Fan X, Du FH, Tian JP. The electrocardiographic changes in acute brain injury patients. Chin Med J (Engl) 2012; 125:3430-3433.
5. Krishnamoorthy V, Prathep S, Sharma D, et al. Association between electrocardiographic findings and cardiac dysfunction in adult isolated traumatic brain injury. Indian J Crit Care Med 2014; 18:570-574.
6. Prathep S, Sharma D, Hallman M, et al. Preliminary report on cardiac dysfunction after isolated traumatic brain injury. Crit Care Med 2014; 42:142-147.
7. Clifton GL, McCormick WF, Grossman RG. Neuropathology of early and late deaths after head injury. Neurosurgery 1981; 8:309-314.
8. Finsterer J, Wahbi K. CNS disease triggering Takotsubo stress cardiomyopathy. Int J Cardiol 2014; 177:322-329.
9. Nguyen H, Zaroff JG. Neurogenic stunned myocardium. Curr Neurol Neurosci Rep 2009; 9:486-491.
10. Krishnamoorthy V, Sharma D, Prathep S, Vavilala MS. Myocardial dysfunction in acute traumatic brain injury relieved by surgical decompression. Case Rep Anesthesiol 2013; 2013:482596.
11. Perkes I, Baguley IJ, Nott MT, Menon DK. A review of paroxysmal sympathetic hyperactivity after acquired brain injury. Ann Neurol 2010; 68:126- 135.
12. Diringer MN, Bleck TP, Claude Hemphill J 3rd, et al., Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care 2011; 15:211- 240.
13. Patel MB, McKenna JW, Alvarez JM, et al. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial. Trials 2012; 13:177.
14. Atkinson JL, Anderson RE, Murray MJ. The early critical phase of severe head injury: importance of apnea and dysfunctional respiration. J Trauma 1998; 45:941-945.
15. Bratton SL, Davis RL. Acute lung injury in isolated traumatic brain injury. Neurosurgery 1997; 40:707-712.
16. Davison DL, Terek M, Chawla LS. Neurogenic pulmonary edema. Crit Care 2012; 16:212.
17. Jepsen CH, deMoya MA, Perner A, et al. Effect of valproic acid and injury on lesion size and endothelial glycocalyx shedding in a rodent model of isolated traumatic brain injury. J Trauma Acute Care Surg 2014; 77:292-297.
18. Wray NP, Nicotra MB. Pathogenesis of neurogenic pulmonary edema. Am Rev Respir Dis 1978; 118:783-786.
19. McClellan MD, Dauber IM, Weil JV. Elevated intracranial pressure increases pulmonary vascular permeability to protein. J Appl Physiol 1989; 67:1185- 1191.
20. Thelandersson A, Cider A, Nellgard B. Prone position in mechanically ventilated patients with reduced intracranial compliance. Acta Anaesthesiol Scand 2006; 50: 937-941.
21. McKinlay J, Chapman G, Elliot S, Mallick A. Preemptive Novalung-Assisted carbon dioxide removal in a patient with chest, head and abdominal injury. Anaesthesia 2008; 63:767-770.
22. Muellenbach RM, Kredel M, Kunze E, et al. Prolonged heparin-free extracorporeal membrane oxygenation in multiple injured acute respiratory distress syndrome patients with traumatic brain injury. J Trauma Acute Care Surg 2012; 72:1444-1447.
23. Davison DL, Chawla LS, Selassie L, et al. Neurogenic pulmonary edema: successful treatment with IV phentolamine. Chest 2012; 141:793-795.
24. Joseph DK, Dutton RP, Aarabi B, Scalea TM. Decompressive laparotomy to treat intractable intracranial hypertension after traumatic brain injury. J Trauma 2004; 57:687-693.
25. Al-Nimer F, Beyeen AD, Lindblom R, et al. Both MHC and non-MHC genes regulate inflammation and T-cell response after traumatic brain injury. Brain Behav Immun 2011; 25:981-990.
26. Frank MG, Weber MD, Watkins LR, Maier SF. Stress sounds the alarmin: The role of the danger-Associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav Immun 2015; 48: 1-7.
27. Rivers-Auty J, Ashton JC. Neuroinflammation in ischemic brain injury as an adaptive process. Med Hypotheses 2014; 82:151-158.
28. Roberts I, Yates D, Sandercock P, et al., CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebocontrolled trial. Lancet 2004; 364:1321-1328.
29. Bye N, Habgood MD, Callaway JK, et al. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol 2007; 204:220-233.
30. Heard SO, Fink MP, Gamelli RL, et al. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group. Crit Care Med 1998; 26:748-754.
31. Loop T, Humar M, Pischke S, et al. Thiopental inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappaB through suppression of kappaB kinase activity. Anesthesiology 2003; 99:360-367.
32. Zhang J, Jiang R, Liu L, et al. Traumatic brain injury-Associated coagulopathy. J Neurotrauma 2012; 29:2597-2605.
33. Vivien D, Ali C. Traumatic brain injury: Tissue-Type plasminogen activator - harmful or beneficial? Nat Rev Neurol 2012; 8:538-539.
34. Lustenberger T, Talving P, Kobayashi L, et al. Early coagulopathy after isolated severe traumatic brain injury: relationship with hypoperfusion challenged. J Trauma 2010; 69:1410-1414.
35. Sillesen M, Rasmussen LS, Jin G, et al. Assessment of coagulopathy, endothelial injury, and inflammation after traumatic brain injury and hemorrhage in a porcine model. J Trauma Acute Care Surg 2014; 76:12-19.
36. Dewan Y, Komolafe EO, Mejía-Mantilla JH, et al., CRASH-3 Collaborators. CRASH-3: Tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebocontrolled trial. Trials 2012; 13:87.
37. Peiniger S, Nienaber U, Lefering R, et al., Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie. Balanced massive transfusion ratios in multiple injury patients with traumatic brain injury. Crit Care 2011; 15:R68.
38. Massaro AM, Doerfler S, Nawalinski K, et al. Thromboelastography defines late hypercoagulability after TBI: A pilot study. Neurocrit Care 2015; 22:45- 51.
39. Abdel-Aziz H, Dunham CM, Malik RJ, Hileman BM. Timing for deep vein thrombosis chemoprophylaxis in traumatic brain injury: An evidence-based review. Crit Care 2015; 19:96.
40. Phelan HA. Venous thromboembolism after traumatic brain injury. Semin Thromb Hemost 2013; 39:541-548.
41. Gordon JL, Fabian TC, Lee MD, Dugdale M. Anticoagulant and antiplatelet medications encountered in emergency surgery patients: A review of reversal strategies. J Trauma Acute Care Surg 2013; 75:475-486.
42. Dusick JR, Wang C, Cohan P, et al. Pathophysiology of hypopituitarism in the setting of brain injury. Pituitary 2012; 15:2-9.
43. Kleindienst A, Brabant G, Bock C, et al. Neuroendocrine function following traumatic brain injury and subsequent intensive care treatment: A prospective longitudinal evaluation. J Neurotrauma 2009; 26:1435-1446.
44. Dimopoulou I, Tsagarakis S, Kouyialis AT, et al. Hypothalamic-pituitary-Adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels. Crit Care Med 2004; 32:404-408.
45. Vespa PM. Hormonal dysfunction in neurocritical patients. Curr Opin Crit Care 2013; 19:107-112.
46. Tsagarakis S, Tzanela M, Dimopoulou I. Diabetes insipidus, secondary hypoadrenalism and hypothyroidism after traumatic brain injury: clinical implications. Pituitary 2005; 8 (3-4):251-254.
47. Wu X, Sha H, Sun Y, et al. N-Terminal pro-B-Type natriuretic peptide in patients with isolated traumatic brain injury: A prospective cohort study. J Trauma 2011; 71:820-825.
48. Lu WY, Rhoney DH, Boling WB, et al. A review of stress ulcer prophylaxis in the neurosurgical intensive care unit. Neurosurgery 1997; 41:416-425.
49. Wang X, Dong Y, Han X, et al. Nutritional support for patients sustaining traumatic brain injury: A systematic review and meta-Analysis of prospective studies. Plos One 2013; 8:e58838.